Localized radiation increases morbidity and mortality after TBI-containing autologous stem cell transplantation in patients with lymphoma

Bone Marrow Transplantation

Volumn 32, Issue 9, 2003, Pages 863-867

  Emmanouilides, C ^a   Asuncion, D J ^a   Wolf, C ^a   Scott, S ^a   Territo, M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autologous transplant; Hodgkin's lymphoma; Lymphoma; Mortality; Pneumonitis; Radiation

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE SULFATE;

ADULT; AGED; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOTRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER RADIOTHERAPY; CAUSE OF DEATH; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DRUG MEGADOSE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MEDIASTINUM; MORBIDITY; MULTIPLE ORGAN FAILURE; NONHODGKIN LYMPHOMA; PATIENT MONITORING; PERIPHERAL BLOOD STEM CELL; PNEUMONIA; PRIORITY JOURNAL; RADIATION BEAM; RADIATION FIELD; SEPSIS; SURVIVAL TIME; SYMPTOMATOLOGY; WHOLE BODY RADIATION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAUSE OF DEATH; COMBINED MODALITY THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; LYMPHOMA; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PNEUMONIA; RADIATION DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SEPSIS; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 0242468188     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704238     Document Type: Article

References (17)

1. Canellos GP, Anderson JR, Propert KJ et al. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 1992; 327: 1478-1484.
2. Specht L, Gray RG, Clarke MJ, Peto R. Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin's disease: a meta-analysis of 23 randomized trials involving 3,888 patients. International Hodgkin's Disease Collaborative Group. J Clin Oncol 1998; 16: 830.
3. Longo DL, Duffey PL, Young RC et al. Conventional-dose salvage combination chemotherapy in patients relapsing with HL after combination chemotherapy: the low probability for cure. J Clin Oncol 1992; 10: 210-218.
4. Lazarus HM, Loberiza Jr FR, Zhang MJ et al. Autrotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry. Bone Marrow Transplant 2001; 27: 387-396.
5. Lazarus HM, Rowlings PA, Zhang MJ et al. Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the autologous blood and marrow transplant registry. J Clin Oncol 1999; 17: 534-545.
6. Fisher RI, Gaynor ER, Dahlberg S et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 1993; 328: 1002-1006.
7. Philip T, Guglielmi C, Hagenbeek A et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemo-sensitive NHL. N Engl J Med 1995; 333: 1540 154.
8. Stiff PJ, Forman SJ, McCall AR et al. Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive Non-Hodgkin's lymphoma: value of augmented preparative regimens - a Southwest Oncology Group Trial. J Clin Oncol 1998; 16: 48-55.
9. Longo DL, Glasttein E, Duffey PL et al. Treatment of localized aggressive lymphomas with combination chemotherapy followed by IFRT. J Clin Oncol 1989; 7: 1295-1302.
10. Parlovsky S, Maschio M, Santarelli MT et al. Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage I-II Hodgkin's disease. J Natl Cancer Inst 1988; 80: 1466-1473.
11. Miller TP, Dahlberg SM, Cassady JR et al. Chemotherapy alone compared to chemotherapy and radiotherapy for localized intermediate and high grade NHL. N Engl J Med 1998; 339: 21-26.
12. Poen JC, Hoppe RT, Horning SJ. High-dose therapy and autologous bone marrow transplantation for relapsed/refractory Hodgkin's disease: the impact of involved field radiotherapy on patterns of failure and survival. Int J Radiat Oncol Biol Phys 1995; 33: 261.
13. Mundt AJ, Sibley G, Williams S et al. Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease. J Clin Oncol 1993; 11: 1062.
14. Yahalom J, Gulati SC, Toia M et al. Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease. J Clin Oncol 1993; 11: 1062-1070.
15. Jules-Ellysee K, Stover DE, Yaholom J et al. Pulmonary complications in lymphoma patients treated with high-dose therapy and autologous bone marrow transplantation. Am Rev Respir Dis 1992; 146: 485-491.
16. Movsas B, Raffin TA, Epstein AH et al. Pulmonary radiation injury. Chest 1997; 111: 1061 1077.
17. Crump M, Smith AM, Brandwein J et al. High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: importance of disease status at transplant. J Clin Oncol 1993; 11: 704-711.